Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1628820 | 0.88 | CA2 (0.33) | CA2CA9 | |
| SCHEMBL29287181 | 0.86 | CA2 (0.32) | CA2CA9 | |
| SCHEMBL3167586 | 0.79 | CA2 (0.30) | CA2 | |
| SCHEMBL10614132 | 0.79 | — | — | |
| SCHEMBL28236559 | 0.79 | — | — | |
| SCHEMBL27669078 | 0.79 | — | — | |
| SCHEMBL253069 | 0.77 | CA2 (0.33) | CA2CA9 | |
| SCHEMBL10843647 | 0.74 | — | — | |
| SCHEMBL8079764 | 0.74 | — | — | |
| SCHEMBL709424 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1828142-B1 | METHOD FOR PRODUCING ONIUM ALKYL SULFATES WITH A LOW HALOGENIDE CONTENT | MERCK PATENT GMBH (DE) | 2010-06-02 | — | — | EP | claimed |
| US-20210378652-A1 | CAMK2D ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF | BRISTOL-MYERS SQUIBB COMPANY | 2021-12-09 | — | — | US | disclosed |
| US-11058767-B2 | CAMK2D antisense oligonucleotides and uses thereof | BRISTOL-MYERS SQUIBB COMPANY (US) | 2021-07-13 | — | — | US | disclosed |
| EP-3755800-A1 | CAMK2D ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF | Bristol-Myers Squibb Company (US) | 2020-12-30 | — | — | EP | disclosed |
| US-20190275148-A1 | CAMK2D ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF | ROCHE INNOVATION CENTER COPENHAGEN A/S (DK) | 2019-09-12 | — | — | US | disclosed |
| WO-2019165067-A1 | CAMK2D ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF | BRISTOL-MYERS SQUIBB COMPANY (US) | 2019-08-29 | — | — | WO | disclosed |
| EP-1828142-B1 | METHOD FOR PRODUCING ONIUM ALKYL SULFATES WITH A LOW HALOGENIDE CONTENT | MERCK PATENT GMBH (DE) | 2010-06-02 | — | — | EP | disclosed |
| EP-1828142-A1 | METHOD FOR PRODUCING ONIUM ALKYL SULFATES WITH A LOW HALOGENIDE CONTENT | Merck Patent GmbH (DE) | 2007-09-05 | — | — | EP | disclosed |
| WO-2006063654-A1 | METHOD FOR PRODUCING ONIUM ALKYL SULFATES WITH A LOW HALOGENIDE CONTENT | MERCK PATENT GMBH (DE) | 2006-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190275148-A1 | CAMK2D ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF | CAMK2D, CAMK1D, CAMK2A | CA2 733/4885CA9 4052/4885 |
| US-11058767-B2 | CAMK2D antisense oligonucleotides and uses thereof | CAMK2D, CAMK1D, CAMK2A | CA2 733/4885CA9 4052/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.